PUBLICATION

Activation of WNT signaling restores the facial deficits in a zebrafish with defects in cholesterol metabolism

Authors
Castro, V.L., Reyes-Nava, N.G., Sanchez, B.B., Gonzalez, C.G., Paz, D., Quintana, A.M.
ID
ZDB-PUB-201120-145
Date
2020
Source
Genesis (New York, N.Y. : 2000)   58(12): e23397 (Journal)
Registered Authors
Quintana, Anita
Keywords
WNT, cholesterol, facial development, neural crest cells
MeSH Terms
  • Neural Crest/embryology
  • Neural Crest/metabolism*
  • Down-Regulation
  • Face/embryology
  • Wnt Signaling Pathway/drug effects*
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism
  • Zebrafish/embryology
  • Zebrafish/genetics*
  • Axin Protein*/genetics
  • Axin Protein*/metabolism
  • Cell Differentiation/drug effects
  • Endothelin-1/genetics
  • Endothelin-1/metabolism
  • Animals
  • Male
  • Alleles
  • Cyclin D1/genetics
  • Cyclin D1/metabolism
  • Gene Expression Regulation, Developmental/drug effects*
  • Transcription Factors/genetics
  • Transcription Factors/metabolism
  • Craniofacial Abnormalities/genetics*
  • Cholesterol/metabolism*
  • Collagen Type II/genetics
  • Collagen Type II/metabolism
  • Embryo, Nonmammalian/metabolism
  • SOXE Transcription Factors/genetics
  • SOXE Transcription Factors/metabolism
  • Female
  • Genotype
  • Phenotype
  • Mutation
(all 33)
PubMed
33197123 Full text @ Genesis
Abstract
Inborn errors of cholesterol metabolism occur as a result of mutations in the cholesterol synthesis pathway (CSP). Although mutations in the CSP cause a multiple congenital anomaly syndrome, craniofacial abnormalities are a hallmark phenotype associated with these disorders. Previous studies have established that mutation of the zebrafish hmgcs1 gene (Vu57 allele), which encodes the first enzyme in the CSP, causes defects in craniofacial development and abnormal neural crest cell (NCC) differentiation. However, the molecular mechanisms by which the products of the CSP disrupt NCC differentiation are not completely known. Cholesterol is known to regulate the activity of WNT signaling, an established regulator of NCC differentiation. We hypothesized that defects in cholesterol synthesis are associated with reduced WNT signaling, consequently resulting in abnormal craniofacial development. To test our hypothesis we performed a combination of pharmaceutical inhibition, gene expression assays, and targeted rescue experiments to understand the function of the CSP and WNT signaling during craniofacial development. We demonstrate reduced expression of four canonical WNT downstream target genes in homozygous carriers of the Vu57 allele and reduced axin2 expression, a known WNT target gene, in larvae treated with Ro-48-8071, an inhibitor of cholesterol synthesis. Moreover, activation of WNT signaling via treatment with WNT agonist I completely restored the craniofacial defects present in a subset of animals carrying the Vu57 allele. Collectively, these data suggest interplay between the CSP and WNT signaling during craniofacial development.
Genes / Markers
Figures
Figure Gallery (2 images)
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Allele Construct Type Affected Genomic Region
co26TgTransgenic Insertion
    vu57
      Point Mutation
      vu234TgTransgenic Insertion
        1 - 3 of 3
        Show
        Human Disease / Model
        No data available
        Sequence Targeting Reagents
        No data available
        Fish
        1 - 2 of 2
        Show
        Antibodies
        No data available
        Orthology
        No data available
        Engineered Foreign Genes
        Marker Marker Type Name
        mRFPEFGmRFP
        TagRFPEFGTagRFP
        1 - 2 of 2
        Show
        Mapping
        No data available